Outcome of the Board Meeting held on May 23, 2026 for Audited Financial Results (Standalone And Consolidated) For The Year Ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Relic Technologies Limited held a Board Meeting on May 23, 2026 where the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 were approved. Statutory auditors D. Kothary & Co. issued an Unmodified (clean) opinion on both standalone and consolidated results. The consolidated results include two subsidiaries: Relic Pharma Limited and Truhealthy Wellness Private Limited. The consolidated total comprehensive income for the year stood at negative Rs 14.47 lakhs. The subsidiary Relic Pharma/Truhealthy reported significant losses of Rs 748.69 lakhs for the year. Standalone total assets decreased from Rs 1,002.85 lakhs to Rs 559.12 lakhs, while consolidated assets reduced from Rs 1,362.92 lakhs to Rs 709.19 lakhs.
The company reported losses at both standalone and consolidated levels for FY2026. The clean audit opinion provides some comfort on financial reporting accuracy, but the declining asset base and subsidiary losses may concern investors.